Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 17;6(2):109-119.
doi: 10.1016/j.gendis.2019.04.001. eCollection 2019 Jun.

Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review

Preeti Pachori  1 , Ragini Gothalwal  1 , Puneet Gandhi  2
Affiliations
Review

Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review

Preeti Pachori et al. Genes Dis. .

Abstract

The emergence of antibiotic resistant bacteria in the healthcare is a serious concern. In the Healthcare premises precisely intensive care unit are major sources of microbial diversity. Recent findings have demonstrated not only microbial diversity but also drug resistant microbes largely habitat in ICU. Pseudomonas aeruginosa found as a part of normal intestinal flora and a significant pathogen responsible for wide range of ICU acquired infection in critically ill patients. Nosocomial infection associated with this organism including gastrointestinal infection, urinary tract infections and blood stream infection. Infection caused by this organism are difficult to treat because of the presence of its innate resistance to many antibiotics (β-lactam and penem group of antibiotics), and its ability to acquire further resistance mechanism to multiple class of antibiotics, including Beta-lactams, aminoglycosides and fluoroquinolones. In the molecular evolution microbes adopted several mechanism to maintain genomic plasticity. The tool microbe use for its survival is mainly biofilm formation, quorum sensing, and horizontal gene transfer and enzyme promiscuity. Such genomic plasticity provide an ideal habitat to grow and survive in hearse environment mainly antibiotics pressure. This review focus on infection caused by Pseudomonas aeruginosa, its mechanisms of resistance and available treatment options. The present study provides a systemic review on major source of Pseudomonas aeruginosa in ICU. Further, study also emphasizes virulence gene/s associated with Pseudomonas aeruginosa genome for extended drug resistance. Study gives detailed overview of antibiotic drug resistance mechanism.

Keywords: Antibiotics; Blood stream infections; Infection; Pathogen; Resistance; Urinary tract infections.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed mechanism of antibiotic resistant in P. aeruginosa.
See this image and copyright information in PMC

References

    1. Boucher H.W., George H., Talbot J. Bad bugs, No drugs: No ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48(1):1–12. - PubMed
    1. Carlet J., Ben A.A., Tabah A. Multidrug resistant infections in the ICU: mechanisms, prevention and treatment. In: Kuhlen R., Moreno R., Ranieri V.M., Rhodes A., editors. 25 Years of Progress and Innovation in Intensive Care Medicine. Medizinisch Wissenschaftliche Verlagsgesellschaft; Berlin, Germany: 2007. pp. 199–211.
    1. Esposito S., Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007;29:494–500. - PubMed
    1. Ranjan N., Chaudhary U., Chaudhry D., Ranjan K.P. Ventilator associated pneumonia in a tertiary care intensive care unit: analysis of incidence, risk factors and mortality. Indian J Crit Care Med. 2007;18:200–204. - PMC - PubMed
    1. Moore L.S., Freeman R., Gilchrist M. Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London. J Antimicrob Chemother. 2014;69(12):3409–3422. - PMC - PubMed

LinkOut - more resources